Overview
Status
Active
Registry date
2023-12-15
Share capital
50,000.00 PLN
Registered address
ul. Nowolipie 25/Lu6, 01-002 Warszawa, Poland
Electronic delivery address
AE:PL-97429-64664-RWJGW-25
Financials
Filing timeliness
No financial statement for 2025 – the filing deadline has passed.
- 2025not filed
- 202403/07/2025
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2024.
Results vs industry
Revenue
This companyUSD 115.28kMedianUSD 443.52kAverageUSD 1.75m
Net profit
This companyUSD -46.72kMedianUSD 14.31kAverageUSD 129.52k
Operating costs
This companyUSD 161.73kMedianUSD 397.10kAverageUSD 1.56m
Assets
This companyUSD 50.18kMedianUSD 173.92kAverageUSD 1.02m
Industry
Authorized Representatives
Angelika Dorota Sikora – President of the Management Board
Mariusz Sikora – Management Board Member
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Angelika Dorota Sikoraage 34 | 50 | $6,753.11 | 50% |
Mariusz Sikoraage 41 | 50 | $6,753.11 | 50% |
Angelika Dorota Sikora and Mariusz Sikora hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2024-06-18.
49 1020 1026 0000 1602 0631 9984
05 1020 1026 0000 1102 0672 1825
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Nectar Polskasp. z o.o. | $528,123.00 | klinikametoda.pl | ||
| Astimedsp. z o.o. | $498,540.18 | astimed.pl | ||
| I. V. Clinicsp. z o.o. | $510,444.80 | ivclinic.com.pl | ||
| MAAMsp. z o.o. | $455,593.52 | urmed.pl | ||
| Saska Medsp. z o.o. | $241,826.45 | saskamed.pl | ||
| Promindsp. z o.o. | $89,181.48 | promindclinic.pl | ||
| Onkomedicasp. z o.o. | $69,344.55 | onkomedica.pl | ||
| Biocells Medicalsp. z o.o. | $11,508.17 | biocellsmedical.com | ||
| Bodyclinicsp. z o.o. | $3,758.46 | bodyclinic.pl | ||
| Regenerumclinicsp. z o.o. | $1,427.86 | regenerumclinic.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-04-15 | Address change (Ul. Bracka 18/2, 00-028, Warszawa → Ul. Nowolipie 25/Lu6, 01-002, Warszawa) | |
| 2023-12-15 | Entered in the register |
FAQ
The main business activity of Sikora Med focuses on specialist medical practice activities.
The company was registered in the Polish National Court Register (KRS) on December 15, 2023.
The headquarters is located at: ul. Nowolipie 25, 01-002 Warszawa.
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from December 15, 2023 to December 31, 2024.
In 2024, the company generated total revenue of $115,282.
No, in 2024 the company was not profitable, reporting a net loss of $46,720.
The largest operating cost category falls under other operating costs. This category amounted to $97,215 in 2024, representing 60% of all operating expenses.
Last updated: 2026-04-28